The clinical manifestations of the C1-INH deficiency are dramatically demonstrated in hereditary angioedema (HAE) in humans, where the principle mediator of subcutaneous and submucosal angioedema is excessive bradykinin production [63]. This evidence concerns the gene KNG1 and hyperinsulinemic hypoglycemia, familial, 4.